← Back to headlines
AstraZeneca's Hypertension Drug Baxfendy Receives US FDA Approval
AstraZeneca has announced that its hypertension drug, Baxfendy, has received approval from the U.S. Food and Drug Administration (FDA). This approval marks a significant step for the treatment of hypertension.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
